Esker - Record Q2 bookings; FY24 outlook maintained
Esker reported Q224 year-on-year constant currency (cc) revenue growth of 14% and bookings annual recurring revenue (ARR) cc growth of 65%....
358 Views
Boku - Strong underlying revenue growth in H124
In H124, digital wallets/account-to-account (A2A) adoption continued, with revenue growth of more than 50% y-o-y. Carrier billing revenues were...
339 Views
Record - Transitional year ahead
Record reported FY24 PBT of £12.9m, down 12% y-o-y and in line with our estimate of £12.8m. Underlying PBT was £14.8m, up 2% y-o-y on record assets...
225 Views
Custodian Property Income REIT - Organic growth paying dividends
Custodian Property Income REIT’s (CREI’s) confidence in its organic growth outlook is reflected in accelerated, fully covered DPS growth....
191 Views
Recce Pharmaceuticals - Taking a closer look at diabetic foot infections
We highlight the opportunity of topical RECCE® 327 (R327) to address diabetic foot infections (DFIs), which is the leading cause of limb morbidity...
189 Views